Webcast is Live at 4:00 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Oct. 29, 2013--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that it will host a live webcast of its fourth
quarter and fiscal year 2013 conference call on Tuesday, November 5, at
4:00 p.m. CT (5:00 p.m. ET). The Company will issue an earnings news
release after the market closes that afternoon.
Gary Maharaj, chief executive officer, and Andy LaFrence, vice president
of finance and chief financial officer, will recap the fourth quarter
and fiscal year 2013 financial results and accomplishments as well as
provide fiscal 2014 guidance. To access the webcast, go to the investor
relations portion of the Company’s website at www.surmodics.com
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7:00 p.m. CT on Tuesday,
November 5, until 7:00 p.m. CT on Tuesday, November 12, and can be
accessed by dialing 800-406-7325 and entering conference call ID
passcode 4647280. In addition, the conference call audio and transcript
will be archived on the Company’s website following the call.
About SurModics, Inc.
SurModics’ mission is to exceed our
customers’ expectations and enhance the well-being of patients by
providing the world’s foremost, innovative surface modification
technologies and in vitro diagnostic chemical components. The
Company partners with the world’s leading and emerging medical device,
diagnostic and life science companies to develop and commercialize
innovative products designed to improve patient diagnosis and treatment.
Core offerings include surface modification coating technologies that
impart lubricity, prohealing, and biocompatibility capabilities; and
components for in vitro diagnostic test kits and microarrays.
SurModics is headquartered in Eden Prairie, Minnesota. For more
information about the Company, visit http://www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
Source: SurModics, Inc.
SurModics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com
